Ingo Borggraefe

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi request reprint Improved gait parameters after robotic-assisted locomotor treadmill therapy in a 6-year-old child with cerebral palsy
    Ingo Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Haunersches Children s Hospital, University of Munich, Germany
    Mov Disord 23:280-3. 2008
  2. ncbi request reprint Sustainability of motor performance after robotic-assisted treadmill therapy in children: an open, non-randomized baseline-treatment study
    I Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Haunersches Children s HospitalUniversity of Munich, Munich, Germany
    Eur J Phys Rehabil Med 46:125-31. 2010
  3. doi request reprint Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study)
    Ingo Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, University of Munich, Munich, Germany
    Eur J Paediatr Neurol 17:507-14. 2013
  4. doi request reprint Safety of robotic-assisted treadmill therapy in children and adolescents with gait impairment: a bi-centre survey
    Ingo Borggraefe
    Ludwig Maximilians University of Munich, Department of Pediatric Neurology and Developmental Medicine, Munich, Germany
    Dev Neurorehabil 13:114-9. 2010
  5. doi request reprint Robotic-assisted treadmill therapy improves walking and standing performance in children and adolescents with cerebral palsy
    Ingo Borggraefe
    Department of Paediatric Neurology and Developmental Medicine, Dr von Haunersches Children s Hospital, University of Munich, Germany
    Eur J Paediatr Neurol 14:496-502. 2010
  6. doi request reprint Return to participation - significant improvement after bilateral pallidal stimulation in rapidly progressive DYT-1 dystonia
    I Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Hauner s Children s Hospital, University of Munich, Munich, Germany
    Neuropediatrics 39:239-42. 2008
  7. doi request reprint The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy
    Florian Heinen
    Department of Paediatric Neurology and Developmental Medicine, Dr von Hauner s Children s Hospital, University of Munich, Lindwurmstr 4, 80337 Munich, Germany
    Eur J Paediatr Neurol 14:45-66. 2010
  8. doi request reprint Bilateral pallidal stimulation in children and adolescents with primary generalized dystonia--report of six patients and literature-based analysis of predictive outcomes variables
    Ingo Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Hauner s Children s Hospital, Ludwig Maximilians University, Lindwurm Street 4, 80337 Munich, Germany
    Brain Dev 32:223-8. 2010
  9. doi request reprint Early globus pallidus internus stimulation in pediatric patients with generalized primary dystonia: long-term efficacy and safety
    Jan Hinnerk Mehrkens
    Department of Neurosurgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    J Child Neurol 25:1355-61. 2010
  10. doi request reprint Muscle atrophy beyond the clinical effect after a single dose of OnabotulinumtoxinA injected in the procerus muscle: a study with magnetic resonance imaging
    Inga K Koerte
    Institute for Clinical Radiology, Ludwig Maximilians University, Munich, Germany
    Dermatol Surg 39:761-5. 2013

Detail Information

Publications18

  1. ncbi request reprint Improved gait parameters after robotic-assisted locomotor treadmill therapy in a 6-year-old child with cerebral palsy
    Ingo Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Haunersches Children s Hospital, University of Munich, Germany
    Mov Disord 23:280-3. 2008
    ..The boy tolerated the trial very well and showed improved function, speed, and endurance of walking. Introducing methods of robotic medicine to pediatrics may help children with central gait impairment to regain motor function...
  2. ncbi request reprint Sustainability of motor performance after robotic-assisted treadmill therapy in children: an open, non-randomized baseline-treatment study
    I Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Haunersches Children s HospitalUniversity of Munich, Munich, Germany
    Eur J Phys Rehabil Med 46:125-31. 2010
    ....
  3. doi request reprint Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study)
    Ingo Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, University of Munich, Munich, Germany
    Eur J Paediatr Neurol 17:507-14. 2013
    ..To show non-inferiority of levetiracetam to sulthiame with respect to efficacy, tolerability and safety in benign epilepsy with centrotemporal spikes in a prospective, double-blinded randomized controlled trial...
  4. doi request reprint Safety of robotic-assisted treadmill therapy in children and adolescents with gait impairment: a bi-centre survey
    Ingo Borggraefe
    Ludwig Maximilians University of Munich, Department of Pediatric Neurology and Developmental Medicine, Munich, Germany
    Dev Neurorehabil 13:114-9. 2010
    ..The aim of the present study was to report on adverse events encountered with robotic-assisted treadmill therapy in children and adolescents with gait disorders...
  5. doi request reprint Robotic-assisted treadmill therapy improves walking and standing performance in children and adolescents with cerebral palsy
    Ingo Borggraefe
    Department of Paediatric Neurology and Developmental Medicine, Dr von Haunersches Children s Hospital, University of Munich, Germany
    Eur J Paediatr Neurol 14:496-502. 2010
    ..The aim of the study was to investigate the effect of robotic-assisted treadmill therapy on standing and walking performance in children and adolescents with cerebral palsy and to determine parameters influencing outcome...
  6. doi request reprint Return to participation - significant improvement after bilateral pallidal stimulation in rapidly progressive DYT-1 dystonia
    I Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Hauner s Children s Hospital, University of Munich, Munich, Germany
    Neuropediatrics 39:239-42. 2008
    ..Postoperatively, her clinical status improved significantly as measured by the Burke-Fahn-Marsden dystonia rating scale and the resolution of a unilateral hip dislocation. Normal participation was regained...
  7. doi request reprint The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy
    Florian Heinen
    Department of Paediatric Neurology and Developmental Medicine, Dr von Hauner s Children s Hospital, University of Munich, Lindwurmstr 4, 80337 Munich, Germany
    Eur J Paediatr Neurol 14:45-66. 2010
    ..The updated European consensus 2009 summarises the current understanding regarding an integrated, multidisciplinary treatment approach using Botulinum toxin for the treatment of children with CP...
  8. doi request reprint Bilateral pallidal stimulation in children and adolescents with primary generalized dystonia--report of six patients and literature-based analysis of predictive outcomes variables
    Ingo Borggraefe
    Department of Pediatric Neurology and Developmental Medicine, Dr von Hauner s Children s Hospital, Ludwig Maximilians University, Lindwurm Street 4, 80337 Munich, Germany
    Brain Dev 32:223-8. 2010
    ..In addition, we strived to find predictors for treatment outcome by review and analysis of previously published studies...
  9. doi request reprint Early globus pallidus internus stimulation in pediatric patients with generalized primary dystonia: long-term efficacy and safety
    Jan Hinnerk Mehrkens
    Department of Neurosurgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    J Child Neurol 25:1355-61. 2010
    ..Early neurosurgical intervention seems to be crucial to prevent irreversible impairment of motor function...
  10. doi request reprint Muscle atrophy beyond the clinical effect after a single dose of OnabotulinumtoxinA injected in the procerus muscle: a study with magnetic resonance imaging
    Inga K Koerte
    Institute for Clinical Radiology, Ludwig Maximilians University, Munich, Germany
    Dermatol Surg 39:761-5. 2013
    ..Botulinum toxin is a powerful and often used agent to treat dynamic rhytides. Focal and reversible neurogenic atrophy is considered to be the relevant mechanism of action...
  11. doi request reprint Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence
    A Sebastian Schroeder
    Department of Paediatric Neurology and Developmental Medicine, Hauner Children s Hospital, Campus Innenstadt, University of Munich, Germany
    Neuropediatrics 43:27-36. 2012
    ..Despite clinical efficacy treatment adherence is influenced by personal and environmental factors of parents and caretakers balancing the short-term clinical benefit versus the burden of intervention...
  12. doi request reprint Seizure semiology reflects spread from frontal to temporal lobe: evolution of hyperkinetic to automotor seizures as documented by invasive EEG video recordings
    Fadime Irsel Tezer
    Epilepsy Center, Dept of Neurology, University of Munich, Munich, Germany, Dept of Neurology, Hacettepe University, School of Medicine, Ankara
    Epileptic Disord 15:338-41. 2013
    ..Published with video sequences]. ..
  13. pmc Anisotropy of transcallosal motor fibres indicates functional impairment in children with periventricular leukomalacia
    Inga Koerte
    Institute of Clinical Radiology, Ludwig Maximilians University, Munich, Germany
    Dev Med Child Neurol 53:179-86. 2011
    ..We characterized this white matter condition by examining callosal microstructure, interhemispheric inhibitory competence (IIC), and mirror movements...
  14. doi request reprint Seizures and stupor during intravenous mannose therapy in a patient with CDG syndrome type 1b (MPI-CDG)
    A Sebastian Schroeder
    Dr von Hauner s Childrens Hospital, Ludwig Maximilians University Munich, Lindwurmstr 4, 80337 Munich, Germany
    J Inherit Metab Dis 33:S497-502. 2010
    ..These may be due to intracellular energy failure. Clinical symptoms of energy deficiency should be treated early and aggressively with intravenous glucose regardless of blood glucose levels. ..
  15. doi request reprint Headache in children: update on complementary treatments
    Stefanie Schetzek
    Department of Paediatric Neurology and Developmental Medicine, Hauner Children s Hospital, University of Munich, Munich, Germany
    Neuropediatrics 44:25-33. 2013
    ..MEDLINE and Cochrane Library were systematically searched for articles dealing with complementary and alternative treatment or prophylaxis of headache and migraine published within the past 20 years...
  16. doi request reprint Migraine-related vertigo and somatoform vertigo frequently occur in children and are often associated
    Thyra Langhagen
    German Center for Vertigo and Balance Disorders IFB, University of Munich, Germany
    Neuropediatrics 44:55-8. 2013
    ..Competent care of childhood migraine should include skill in detecting both the clinical symptoms of vertigo and overlapping somatoform symptoms...
  17. doi request reprint Epilepsy surgery: a critical review
    Soheyl Noachtar
    Epilepsy Center, Department of Neurology, University of Munich, Munich, Germany
    Epilepsy Behav 15:66-72. 2009
    ..Furthermore, experimental approaches are mentioned and the reasons for failures of epilepsy surgery are critically discussed...
  18. doi request reprint Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers
    A Sebastian Schroeder
    Department of Pediatric Neurology and Developmental Medicine, Dr von Hauner s Children s Hospital, University of Munich, Munich, Germany
    Mov Disord 24:1494-503. 2009
    ..Neurogenic muscle atrophy following a single BoNT/A injection should be taken into consideration when repeated BoNT/A injections into the same muscles are proposed...